These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23127721)

  • 21. Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol.
    Rugolotto S; Beghini R; Cogo I; Sidoti G; Padovani EM; Pietrobelli A
    Pediatr Med Chir; 2013; 35(5):223-4. PubMed ID: 24516943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.
    Badesch DB; McGoon MD; Barst RJ; Tapson VF; Rubin LJ; Wigley FM; Kral KM; Raphiou IH; Crater GD
    J Rheumatol; 2009 Oct; 36(10):2244-9. PubMed ID: 19723905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treprostinil for the treatment of pulmonary arterial hypertension.
    Torres F; Rubin LJ
    Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy.
    Myers SA; Ahearn GS; Angelica Selim M; Tapson VF
    J Am Acad Dermatol; 2004 Jul; 51(1):98-102. PubMed ID: 15243533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
    Desole S; Velik-Salchner C; Fraedrich G; Ewert R; Kähler CM
    Heart Lung; 2012; 41(6):599-605. PubMed ID: 22920608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
    Farber HW; Graven KK; Kokolski G; Korn JH
    J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin].
    Boucly A; O'Connell C; Savale L; O'Callaghan DS; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
    Presse Med; 2016 Jan; 45(1):20-8. PubMed ID: 26547673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV; Genthner DE; Panella MM; Rich S
    N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Massive ascites in pulmonary arterial hypertension: caution with epoprostenol.
    Kataoka M; Yanagisawa R; Yoshino H; Satoh T
    Ann Am Thorac Soc; 2013 Dec; 10(6):726-7. PubMed ID: 24364782
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral prostacyclin therapy for pulmonary arterial hypertension: another step forward.
    Waxman AB
    Circulation; 2013 Feb; 127(5):563-5. PubMed ID: 23307828
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with ARDS.
    Dahlem P
    Intensive Care Med; 1999 Dec; 25(12):1474-5. PubMed ID: 10660861
    [No Abstract]   [Full Text] [Related]  

  • 33. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.
    Gomberg-Maitland M; Tapson VF; Benza RL; McLaughlin VV; Krichman A; Widlitz AC; Barst RJ
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1586-9. PubMed ID: 16151039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.
    Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxical effect of prostacyclin infusion in a patient with primary pulmonary hypertension-a case report.
    Younger JR; Lui CY
    Angiology; 2004; 55(3):341-4. PubMed ID: 15156270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic review.
    Park K; Ostrow D; Levy RD; Swiston J
    Can Respir J; 2011; 18(3):157-62. PubMed ID: 21766080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous catheter infections in pulmonary arterial hypertension.
    Gaine S; Gomberg-Maitland M
    Int J Clin Pract Suppl; 2008 Jul; (160):3-4. PubMed ID: 18638169
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nebulized prostacyclin treatment for pulmonary hypertension in a 2-year-old girl].
    Puigarnau Vallhonrat R; Pons Odena M; Carballo Ruano E
    An Esp Pediatr; 2000 Oct; 53(4):372-6. PubMed ID: 11083992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.